FranckeDE. The importance of an historical perspective. Drug Intell Clin Pharm1974;8:55.
2.
BrodieDC. Drug-use control: keystone to pharmaceutical service. Drug Intell1967;1:63–5.
3.
FranckeDE. Let's separate pharmacies and drugstores. Am J Pharm1969;141:161–70.
4.
FranckeDE, SmithDL. The social psychological role of the pharmacist in drug usage. In: FranckeDE, WhitneyHAKJr, eds. Perspectives in clinical pharmacy. A textbook for the clinically-oriented pharmacist wherever he may practice. 1st ed. Hamilton, IL: Drug Intelligence Publications, 1972:37–59.
5.
FranckeDE. Levels of pharmacy practice. Drug Intell Clin Pharm1976;10:534–5.
6.
FranckeDE. The new role of pharmacy. Drug Intell1968;2:291.
7.
McLeodDC, WhitneyHAKJr.The legacy of Donald E. Francke: DICP—a fifteen-year commitment to clinical pharmacy. Drug Intell Clin Pharm1981;15:990–1.
8.
WhitneyHAKJr.A sketch of Donald E. Francke, founder and first editor. DICP Ann Pharmacother1991;25:425–6.
9.
McLeodDC. Contribution of The Annals of Pharmacotherapy to the development of clinical pharmacy. Ann Pharmacother2006;40:109–11. Epub 5 Jan 2006. DOI 10.1345/aph.1G547
10.
PhillipsGL. 1973 Harvey A. K. Whitney Lecture: Uncle Harvey. Am J Hosp Pharm1973;30:886–91.
11.
WhitneyHAK. Hospital pharmacy internships. J Am Pharm Assoc1939;28:167–71.
12.
FranckeDE. Drug Intelligence—objectives and scope. Drug Intell1967;1:5.
13.
FranckeGN. Evolvement of clinical pharmacy. Drug Intell Clin Pharm1969;3:348–54.
14.
EckelFM. The need for pharmacy service in nursing homes. Drug Intell1967;1:33–6.
15.
OliverJA. An improved concept for hospital pharmacy service: Memorial Hospital of Long Beach. Drug Intell1967;1:73–5.
16.
FranckeDE. The clinical pharmacist. Drug Intell1967;1:243.
17.
DerewiczHJ. Why a pharmacy and therapeutics committee?Drug Intell1967;1:30–2.
18.
WaltonCA. Education and training of the drug information specialist. Drug Intell1967;1:133–7.
19.
SmithWE. Role of a pharmacist in improving rational drug therapy as part of the patient care team. Drug Intell1967;1:244–9.
20.
BurkholderDF. New dimensions in aiding the objectives of the pharmacy & therapeutics committee. Drug Intell1968;2:35–7.
21.
SmithJE, CanadaATJr.The pharmacist's role in drug surveillance. Drug Intell1967;1:278–81.
22.
FranckeDE. The interdisciplinary of medication errors. Drug Intell1967;1:341.
23.
CanadaATJr.Adverse drug reactions—some problems of definition, interpretation, and reporting. Drug Intell1967;1:372–7.
24.
BergmanHD, FletcherHP, SperandioGJ. Documentation of clinical pharmacy activities in a VA hospital. Drug Intell Clin Pharm1974;8: 656–62.
25.
DunphyT, CaseR, ContinelliB, SisterM Gertrude, SisterM Vera, BurkholderD.A collaborative hospital program for clinical teaching. Drug Intell1969;3:39–41.
26.
FranckeDE. Directions for clinical pharmacy. Drug Intell Clin Pharm1974;8:631.
27.
LongeRL, CalvertJC. Physical assessment and the clinical pharmacist. Drug Intell Clin Pharm1977;11:200–3.
28.
HartshornEA. Drug interactions—general considerations. Drug Intell1968;2:4–7.
29.
WagnerJG. Pharmacokinetics. 1. Definitions, modeling and reasons for measuring blood levels and urinary excretion. Drug Intell1968;2:38–42.
30.
HirschmanJL, MaudlinRK. Drug Information Analysis Service—the DIAS Rounds. Drug Intell Clin Pharm1970;4:10–2.
31.
FranckeDE. The pharmacist prescriber. Drug Intell Clin Pharm1977;11:105, 128.
32.
SegalR, GrinesLL. Prescribing authority for pharmacists as viewed by organized pharmacy, organized medicine, and the pharmaceutical industry. Drug Intell Clin Pharm1988;22:241–6.
33.
LinsteadH.Shaping the pharmacist's role in society. Drug Intell1967;1:142–3.
34.
FosterMS. Ol' Doc Adams vs. “dig” levels (letter). Drug Intell Clin Pharm1981;15:391–2.
35.
American College of Clinical Pharmacy. Drug Intell Clin Pharm 1979;13:564.
36.
WhitneyHAKJr.The creation of the American College of Clinical Pharmacy. Drug Intell Clin Pharm1979;13:608.
37.
VIP News. Drug Intell Clin Pharm 1988:22:648.
38.
McLeodD.Announcing first chairman for editorial board. Drug Intell Clin Pharm1979;13:3.
39.
WhitneyHAKJr.An official journal for the American College of Clinical Pharmacy. Drug Intell Clin Pharm1985;19:920
40.
HainesST. Making residency training an expectation for pharmacists in direct patient care roles. Am J Pharmaceut Educ2007;71:71.
41.
FranckeDE. Specialization within hospital pharmacy. Drug Intell1967;1:85.
42.
FranckeDE. Specialization in pharmacy. Drug Intell Clin Pharm1974;8:105.
43.
WhitneyHAKJr.The journal for drug therapy decision makers. Drug Intell Clin Pharm1979;13:42.
44.
McLeodDC. Specialization in clinical pharmacy. Drug Intell Clin Pharm1987;21:990–1.
45.
Du VailE, LashSD. Counseling the oncology patient. Drug Intell Clin Pharm1984;18:743–4.
46.
CohenJL, NahataMC, RocheVF. Pharmaceutical care in the 21st century: from pockets of excellence to standard of care: report of the 2003–04 Argus Commission. Am J Pharmaceut Educ2004;68:S09.
47.
McLeodDC. Pharmacy technologists (letter). Drug Intell Clin Pharm1974;8:614.
48.
WhitneyHAKJr, GardnerS, SitzlerL. The impact of the pharmacy technologist upon pharmacy practice in the year 2000. Drag Intell Clin Pharm1975;9:434–8.
49.
WhitneyHAKJr.The education and utilization of pharmacy supportive personnel. Drug Intell Clin Pharm1975;9:452–3.
50.
WhitneyHAKJr.Pharmacy technicians establish an independent national organization. Drug Intell Clin Pharm1981;15:281.